Our client wanted to organise an advisory board to seek guidance from a range of stakeholders within...
Read moreOur client wanted to gain an understanding of payer willingness to pay and determine the likely clin...
Read moreOur client required focused payer value messages for their orphan drug as payers were not recognizin...
Read moreOur client wanted to gain a better understanding of current and forthcoming policy measures affectin...
Read moreDevelopment and submission of payer communication materials and pricing and reimbursement dossiers f...
Read moreOncology products, advanced therapy medicinal products (ATMPs) and medical devices are entering the ...
Read moreWe explore what the joint clinical assessment (JCA) is, its process and what future developments may...
Read moreWe summarise the World EPA Congress 2023 including plenary sessions on EU HTA, market archetypes, he...
Read moreCollectively, companies still owe AIFA €370 million of the €2.8 billion that industry has to rep...
Read moreGermany's BPI and vfa advise that the implementation of the European Health Technology Assessment (E...
Read more